Given that EpCAM-positive CSCs are responsible for tumor resistance to chemotherapy, targeting EpCAM might be a promising approach to effectively eradicate ovarian CSCs as the putative root of ovarian cancer [45, 46]. The gene discussed is EPCAM; the disease is ovarian carcinoma.